ALDXAldeyra Therapeutics, Inc.同业对比
Aldeyra Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALDX本股 | $32M#7 | — | 0.8x#10 | — | — | 39.4%#4 | — | -89.3%#8 | — | — | — | — |
| BMEA | $45M#1 | — | 3.7x#12 | — | — | 55.4%#2 | — | -509.2%#14 | — | — | -54.5%#2 | — |
| APUS | $4M#16 | — | 0.0x#1 | — | — | -331.7%#13 | — | -5.6%#1 | -11.2%#1 | — | -86.6%#5 | — |
| ELTX | $44M#2 | — | 5.6x#14 | 19.3x#5 | -91.9%#5 | 23.8%#6 | -1639.0%#5 | -498.6%#13 | — | — | — | — |
| DWTX | $42M#3 | 0.7x#1 | 0.6x#7 | — | — | -177.4%#10 | — | -50.1%#4 | — | — | -80.8%#3 | — |
| SCYX | $37M#4 | 13.4x#2 | 0.6x#5 | 1.8x#3 | 449.9%#1 | 59.6%#1 | -78.0%#2 | -12.9%#2 | — | 7#1 | — | — |
| VERU | $37M#5 | — | 1.3x#11 | 2.2x#4 | 3.6%#3 | 39.9%#3 | -146.6%#3 | -80.1%#6 | -399.3%#4 | — | — | 0.0%#1 |
| NNVC | $35M#6 | — | 4.0x#13 | — | — | 13.2%#7 | — | -94.7%#9 | -78.2%#3 | — | -18.6%#1 | — |
| ACET | $32M#8 | — | 0.3x#2 | — | — | 0.3%#8 | — | -97.2%#10 | — | — | — | — |
| RNAZ | $30M#9 | — | — | — | — | -106.9%#9 | — | — | — | — | — | — |
| LITS | $30M#10 | — | 0.7x#8 | — | -100.0%#6 | -346.2%#14 | — | -170.9%#12 | — | — | — | — |
| FLNA | $29M#11 | — | 0.4x#4 | 0.7x#2 | 277.6%#2 | -273.7%#12 | -232.0%#4 | -133.5%#11 | — | — | -81.4%#4 | — |
| RMTI | $29M#12 | 240.3x#3 | 0.8x#9 | 0.4x#1 | -31.8%#4 | -1007.1%#15 | -6.8%#1 | -15.1%#3 | -14.0%#2 | 4#2 | — | — |
| HEPA | $29M#13 | — | 22.4x#15 | — | — | 37.3%#5 | — | -647.5%#15 | — | — | — | — |
| PMN | $28M#14 | — | 0.6x#6 | — | — | -1529.3%#16 | — | -80.4%#7 | — | — | — | — |
| AARD | $28M#15 | — | 0.4x#3 | — | — | -179.7%#11 | — | -77.0%#5 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议